Bone turnover markers for early detection of fracture healing disturbances: A review of the scientific literature

Anais da Academia Brasileira de Ciencias

Volumn 87, Issue 2, 2015, Pages 1049-1061

  Sousa, Cristina P ^a,b,c   Dias, Isabel R ^a,b,c   Lopez Peña, Mónica ^d   Camassa, José A ^a   Lourenço, Paulo J ^e,f   Judas, Fernando M ^e,f   Gomes, Manuela E ^b,c   Reis, Rui L ^b,c  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Bone formation markers; Bone resorption markers; Delayed union; Fracture healing; Non union process; Osteoclast regulatory proteins

Indexed keywords

BIOLOGICAL MARKER;

BONE REMODELING; EARLY DIAGNOSIS; FRACTURE; FRACTURE HEALING; FRACTURES, UNUNITED; HUMAN; METABOLISM; PHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT;

BIOMARKERS; BONE REMODELING; EARLY DIAGNOSIS; FRACTURE HEALING; FRACTURES, BONE; FRACTURES, UNUNITED; HUMANS; PROGNOSIS; RISK ASSESSMENT;

EID: 84935126079     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/0001-3765201520150008     Document Type: Article

References (54)

1. ASAGIRI M and TAKAYANAGI H. 2007. The molecular understanding of osteoclast differentiation. Bone 40: 251-264.
2. AUBIN JE. 2008. Mesenchymal stem cells and osteoblast differentiation. In: Bilezikian JP, Raisz LG and Martin TJ (Eds), Principles of Bone Biology. 3rd ed., San Diego: Academic Press, p. 85-107.
3. BAARDEWIJK L, ENDE J, Lissenberg-Thunnissen S, ROMIJN LM, HAWINKELS LJ, SIER CF and SCHIPPER IB. 2013. Circulating bone morphogenetic protein levels and delayed fracture healing. Int Orthop 37: 523-527.
4. BISHOP JA, PALANCA AA, BELLINO MJ and LOWENBERG DW. 2012. Assessment of compromised fracture healing. J Am Acad Orthop Surg 20: 273-282.
5. BOWLES SA, KURDY N, DAVIS AM, FRANCE MW and MARSH DR. 1996. Serum osteocalcin, total and bone-specific alkaline phosphatase following isolated tibial shaft fracture. Ann Clin Biochem 33(Pt 3): 196-200.
6. BUCHWALTER JA, EINHORN TA, MARSH LJ, GULOTTA L, RANAWAT A and LANE J. 2010. Bone and joint healing. In: Buchholz RW, Court-Brown C, Heckman JD and Tornetta III P (Eds), Rockwood and Green’s Fractures in Adults. 7th ed., Philadelphia Lippincott: Williams & Wilkins, p. 85-103.
7. CALORI GM, ALBISETTI W, AGUS A, IORI S and TAGLIABUE L. 2007. Risk factors contributing to fracture non-unions. Injury 38(Suppl. 2): S11-18.
8. CLOWES JA, HANNON RA, YAP TS, HOYLE NR, BLUMSOHN A and EASTELL R. 2002. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30: 886-890.
9. COLOMBINI A, LOMBARDI G, GALLIERA E, DOGLIOTTI G, RANDELLI P, MEERSSEMANN A, MINEO G, CABITZA P and CORSI MM. 2011. Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. Int Orthop 35: 777-782.
10. COULIBALY MO, SIETSEMA DL, BURGERS TA, MASON J, WILLIAMS BO and JONES CB. 2010. Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing. Crit Rev Eukaryot Gene Expr 20: 105-127.
11. Court-Brown C and MCQUEEN M. 1987. Compartment syndrome delays tibial union. Acta Orthop Scand 58: 249-252.
12. COX G, EINHORN TA, TZIOUPIS C and GIANNOUDIS PV. 2010. Bone-turnover markers in fracture healing. J Bone Joint Surg Br 92: 329-334.
13. CREMERS S, GARNERO P and SEIBEL MJ. 2008. Biochemical Markers of Bone Metabolism. In: Bilezikian JP, Raisz LG and Martin TJ (Eds), Principles of Bone Biology. 3rd ed., San Diego: Academic Press, p. 1857-1881.
14. EMAMI A, LARSSON A, Petren-Mallmin M and LARSSON S. 1999. Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res 368: 220-229.
15. GERDHEM P et al. 2004. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19: 386-393.
16. GIANNOUDIS PV, MACDONALD DA, MATTHEWS SJ, SMITH RM, FURLONG AJ and DE BOER P. 2000. Nonunion of the femoral diaphysis. The influence of reaming and nonsteroidal anti-inflammatory drugs. J Bone Joint Surg Br 82: 655-658.
17. HALLEEN JM. 2003. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Anticancer Res 23: 1027-1029.
18. HERNANDEZ RK, DO TP, CRITCHLOW CW, DENT RE and JICK SS. 2012. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop 83: 653-660.
19. HERRMANN M, KLITSCHER D, GEORG T, FRANK J, MARZI I and HERRMANN W. 2002. Different kinetics of bone markers in normal and delayed fracture healing of long bones. Clin Chem 48: 2263-2266.
20. KHOSLA S. 2001. Minireview: The OPG/RANKL/RANK system. Endocrinology 142: 5050-5055.
21. KLEIN P, BAIL HJ, SCHELL H, MICHEL R, AMTHAUER H, BRAGULLA H and DUDA GN. 2004. Are bone turnover markers capable of predicting callus consolidation during bone healing? Calcif Tissue Int 75: 40-49.
22. KOMNENOU A, KARAYANNOPOULOU M, POLIZOPOULOU ZS, CONSTANTINIDIS TC and DESSIRIS A. 2005. Correlation of serum alkaline phosphatase activity with the healing process of long bone fractures in dogs. Vet Clin Pathol 34: 35-38.
23. KOMORI T. 2013. Functions of the osteocyte network in the regulation of bone mass. Cell Tissue Res 352: 191-198.
24. KURDY NM. 2000. Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J Orthop Trauma 14: 48-53.
25. JOERRING S, JENSEN LT, ANDERSEN GR and JOHANSEN JS. 1992. Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch Orthop Trauma Surg 111: 265-267.
26. JOERRING S, KROGSGAARD M, WILBEK H and JENSEN LT. 1994. Collagen turnover after tibial fractures. Arch Orthop Trauma Surg 113: 334-336.
27. LANDGRAEBER S, LOER F, HEEP H, CLASSEN T, GRABELLUS F, TOTSCH M and VON KNOCH M. 2010. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement. Arch Orthop Trauma Surg 130: 441-445.
28. LAURER HL, HAGENBOURGER O, QUAST S, HERRMANN W and MARZI I. 2000. Sequential changes and pattern of bonespecific alkaline phosphatase after trauma. Eur J Trauma 1: 33-38.
29. LAWTON DM, ANDREW JG, MARSH DR, HOYLAND JA and FREEMONT AJ. 1997. Mature osteoblasts in human nonunion fractures express collagen type III. Mol Pathol 50: 194-197.
30. LEEMING DJ, ALEXANDERSEN P, KARSDAL MA, QVIST P, SCHALLER S and TANKO LB. 2006. An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 62: 781-792.
31. LI J et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97: 1566-1571.
32. MARCHELLI D, PIODI LP, CORRADINI C, PARRAVICINI L, VERDOIA C and ULIVIERI FM. 2009. Increased serum OPG in atrophic nonunion shaft fractures. J Orthop Traumatol 10: 55-58.
33. MARSH DR and LI G. 1999. The biology of fracture healing: Optimising outcome. Br Med Bull 55: 856-889.
34. MOGHADDAM A, MULLER U, ROTH HJ, WENTZENSEN A, GRUTZNER PA and ZIMMERMANN G. 2011. TRACP 5b and CTX as osteological markers of delayed fracture healing. Injury 42: 758-764.
35. MUKHOPADHYAY M, SINHA R, PAL M, BHATTACHARYYA S, DAN A and ROY MM. 2011. Role of common biochemical markers for the assessment of fracture union. Indian J Clin Biochem 26: 274-248.
36. OBRANT KJ, MERLE B, BEJUI J and DELMAS PD. 1990. Serum bone-gla protein after fracture. Clin Orthop Relat Res (258): 300-303.
37. ONI OO, MAHABIR JP, IQBAL SJ and GREGG PJ. 1989. Serum osteocalcin and total alkaline phosphatase levels as prognostic indicators in tibial shaft fractures. Injury 20: 37-38.
38. QVIST P, CHRISTGAU S, PEDERSEN BJ, SCHLEMMER A and CHRISTIANSEN C. 2002. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31: 57-61.
39. SARAHRUDI K, THOMAS A, MOUSAVI M, KAISER G, KÖTTSTORFER J, KECHT M, HAJDU S and AHARINEJAD S. 2011. Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing. Injury 42: 833-837.
40. SCHLEMMER A and HASSAGER C. 1999. Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Eur J Endocrinol 140: 332-337.
41. SEIBEL MJ. 2000. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 11(Suppl. 6): S18-29.
42. SEIBEL MJ. 2005. Biochemical markers of bone turnover: Part I: Biochemistry and variability. Clin Biochem Rev 26: 97-122.
43. SEIBEL MJ. 2006. Clinical application of biochemical markers of bone turnover. Arq Bras Endocrinol Metabol 50: 603-620.
44. SEIBEL MJ, LANG M and GEILENKEUSER WJ. 2001. Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 47: 1443-1440.
45. SINGH AJAI AS, MAHDI AA and SRIVASTAVA RN. 2013. Evaluation of serum alkaline phosphatase as a biomarker of healing process progression of simple diaphyseal fractures in adult patients. Int Res J Biol Sci 2: 40-43.
46. SOUBERBIELLE JC, CORMIER C and KINDERMANS C. 1999. Bone markers in clinical practice. Curr Opin Rheumatol 11: 312-219.
47. SOUSA C, ABREU H, AZEVEDO JT, VIEGAS CA, REIS RL, GOMES ME and DIAS IR. 2011. Serum total and bone alkaline phosphatase and tartrate-resistant acid phosphatase activities for the assessment of bone fracture healing in dogs. Arq Bras Med Vet Zoot 63: 1007-1011.
48. SOUTHWOOD LL, FRISBIE DD, KAWCAK CE and MCILWRAITH CW. 2003. Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits. Am J Vet Res 64: 727-735.
49. STOFFEL K, ENGLER H, KUSTER M and RIESEN W. 2007. Changes in biochemical markers after lower limb fractures. Clin Chem 53: 131-134.
50. TEITELBAUM SL and ROSS FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649.
51. THEOLEYRE S, WITTRANT Y, TAT SK, FORTUN Y, REDINI F and HEYMANN D. 2004. The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 15: 457-475.
52. VEITCH SW, FINDLAY SC, HAMER AJ, BLUMSOHN A, EASTELL R and INGLE BM. 2006. Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos Int 17: 364-372.
53. ZIMMERMANN G, HENLE P, KÜSSWETTER M, MOGHADDAM A, WENTZENSEN A, RICHTER W and WEISS S. 2005. TGF-β1 as a marker of delayed fracture healing. Bone 36: 779-785.
54. ZIMMERMANN G, MUELLER U and WENTZENSEN A. 2007. The value of laboratory and imaging studies in the evaluation of long-bone non-unions. Injury 38: S33-S37.